HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Colgate-Palmolive trade programs

This article was originally published in The Rose Sheet

Executive Summary

Colgate toothpaste marketer is increasing its emphasis on trade spending with "sharper" programs to win consumers at-shelf, while also working to strengthen its partnership programs with retailers, President and CEO Ian Cook told analysts at the Barclays Back-To-School Consumer Conference Sept. 7. Programs that engage the consumer at the shelf could be key to sales over competitor products, as between 50% to 70% of the final purchase decision is made at the point of sale, the exec noted. "These in-store activities relate to trial for new products as we are doing with our ColgateSensitive Pro-Relief," Cook said. In Poland, the company employs a person in retail doors who explains the benefits of Pro-Relief to shoppers. Last year, the firm announced it would take steps to create an in-store "emotional connection" with financially strapped consumers via shelf programs that create a value proposition (1"The Rose Sheet" Feb. 2, 2009)

You may also be interested in...



Colgate Seizes Chance To Reconnect With Consumers In Sluggish Ad Market

Colgate-Palmolive is capitalizing on a slumping ad market by purchasing media at a lower cost and launching campaigns that strengthen its emotional connection with consumers, the firm reported during an analyst meeting Jan. 29

China Commits To Patent Linkage And Extensions In US Trade Deal

The first phase of a major trade agreement just signed by the US and China obliges the latter to implement a system linking pharma patent enforcement to marketing authorization procedures as well as to offer patent-term extensions. 

 

Recent And Upcoming FDA Advisory Committee Meetings

Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.

UsernamePublicRestriction

Register

RS017184

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel